Research and Reports in Tropical Medicine is a distinguished open-access journal dedicated to advancing knowledge in the field of tropical medicine. Published by DOVE MEDICAL PRESS LTD, this journal operates under the ISSN 1179-7282, facilitating global access to quality research since its inception in 2010. With a commitment to disseminating innovative findings and critical analyses, the journal serves as a vital platform for researchers, professionals, and students engaged in the diverse aspects of tropical diseases and public health challenges. Research and Reports in Tropical Medicine welcomes original research articles, reviews, and case studies that contribute to an improved understanding of health issues in tropical regions, making it an essential resource for those aiming to impact global health positively.

Travel Behaviour and Society is a leading peer-reviewed journal published by Elsevier, focusing on the interdisciplinary field of travel behavior, urban mobility, and transportation dynamics. Established in 2014, this journal serves as a vital platform for academics, researchers, and practitioners who examine the socio-economic and ecological implications of travel and mobility patterns. The journal boasts impressive Q1 quartile rankings in both Geography, Planning and Development and Transportation categories for 2023, placing it among the top tier of publications in these fields. With highly regarded Scopus Rankings, including a remarkable 94th percentile in Geography and 83rd in Transportation, Travel Behaviour and Society seeks to advance theoretical and empirical knowledge while fostering innovative approaches to understanding travel behavior in rapidly evolving urban environments. Researchers and practitioners alike are encouraged to contribute and access the latest findings that are pivotal to shaping sustainable transit policies and enhancing societal well-being.

Travel Medicine and Infectious Disease is a premier peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing the field of travel medicine and infectious disease research. With an impressive impact factor and a category ranking of Q1 in both Infectious Diseases and Public Health, Environmental and Occupational Health, this journal is recognized as a leading source of high-quality research and insights. Originating in 2003 and transitioning to an Open Access model in 2023, it aims to disseminate critical findings that enhance the understanding of health risks associated with travel, vaccination strategies, and infectious disease outbreaks. The journal’s Scopus rankings reflect its influence, with a rank of 7/665 in Public Health and 20/344 in Infectious Diseases. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest trends and developments in travel-related health challenges.

Infectious Diseases of Poverty, published by BMC, is a leading open-access journal dedicated to addressing the critical intersection of infectious diseases and poverty. Since its inception in 2012, this influential journal has contributed significantly to the fields of public health, infectious diseases, and environmental health. With impressive rankings placing it in the top quartile (Q1) across multiple categories—including Infectious Diseases and Public Health, Environmental and Occupational Health—it stands as a vital resource for researchers and practitioners alike. The journal's commitment to accessibility ensures that high-quality research is available to a global audience, fostering collaboration and knowledge sharing. Based in the UK, Infectious Diseases of Poverty aims to publish innovative research that sheds light on the complexities of infectious diseases and their socio-economic determinants, ultimately working to improve health outcomes in vulnerable populations around the world. With its robust impact factor and esteemed standing within the academic community, this journal serves as an essential platform for advancing the understanding and management of infectious diseases related to poverty.

ACTA TROPICA is a prestigious academic journal published by Elsevier, dedicated to advancing knowledge in the fields of Infectious Diseases, Insect Science, Parasitology, and Veterinary sciences. With an ISSN of 0001-706X and an E-ISSN of 1873-6254, it has established itself as a vital resource since its inception in 1945. The journal is recognized for its significant impact within the scientific community, boasting a Q2 ranking in Infectious Diseases and Parasitology, and a Q1 ranking in both Insect Science and Veterinary (miscellaneous) categories as of 2023. Specifically, it ranks #19 in Scopus for Parasitology and #129 for Infectious Diseases, underscoring its high visibility and relevance in these vital research arenas. ACTA TROPICA is a non-open access journal, ensuring high-quality peer-reviewed content that complements ongoing research and professional practices among scientists, researchers, and students. Explore groundbreaking studies and contribute to the ongoing dialogue within your field by selecting ACTA TROPICA as your next publication destination.

Current Tropical Medicine Reports, published by Springer, is an esteemed journal that serves as a pivotal platform for researchers, professionals, and students in the fields of immunology, allergy, and infectious diseases. With a strong focus on emerging tropical medicine topics, the journal provides an authoritative avenue for disseminating innovative research and practical insights, showcasing its commitment to advancing global health knowledge. Now in its convergence years from 2014 to 2024, it has successfully established itself in the academic community, evidenced by its Q2 rankings in the categories of Infectious Diseases and Immunology and Allergy in 2023, reflecting its impact and relevance. The journal boasts impressive Scopus rankings, holding the 50th position in Infectious Diseases and 55th in Immunology and Allergy, further underscoring its significance in these critical fields. While it operates under a subscription model, the journal serves not only as a resource for published research but also as a catalyst for collaboration and knowledge exchange among the scientific community. With a growing readership, Current Tropical Medicine Reports is poised to continue shaping the discourse surrounding tropical health challenges.

Journal of Infection in Developing Countries, published by J INFECTION DEVELOPING COUNTRIES, is a premier open-access journal dedicated to advancing research in the fields of infectious diseases, microbiology, parasitology, and virology, particularly within the context of developing nations. Established in 2007 and actively disseminating knowledge since 2008, this journal aims to bridge the gap between researchers and practitioners by providing a platform for high-quality, peer-reviewed articles that address the unique challenges faced in these regions. With an ISSN of 1972-2680 and a robust HIndex showcasing its growing influence, JIDC has attained a Q3 category ranking in several disciplines as of 2023, indicating its crucial role in shaping ongoing discourse in public health. As an open-access publication, it ensures that vital research is accessible to all, fostering collaboration and innovation in infectious disease management and control.

Expert Review of Vaccines, published by Taylor & Francis Ltd, is a pivotal open access journal that has established itself as a leading source of peer-reviewed articles focusing on vaccine research, development, and policy. With an impressive categorization in the top quartile (Q1) across various domains including Drug Discovery, Immunology, Molecular Medicine, and Pharmacology for 2023, this journal plays a crucial role in disseminating high-quality scientific findings that drive advances in the field. Located in the United Kingdom, it serves a global audience of researchers, healthcare professionals, and students seeking to stay abreast of cutting-edge developments in vaccination strategies and technologies. The journal’s Scopus ranks further attest to its excellence, boasting remarkable placements in Pharmacology and Drug Discovery, reflecting its impact and reach. Since transitioning to an open access format in 2023, the journal has enhanced accessibility to vital research, empowering a broader audience to contribute to and engage with the discourse surrounding vaccines. As the field of immunization continues to evolve, Expert Review of Vaccines remains a cornerstone for those committed to advancing knowledge and practice in this essential area of health science.

Vaccine: X, published by Elsevier, is a premier open access journal dedicated to advancing research in the interdisciplinary fields of immunology and microbiology, infectious diseases, molecular medicine, and public health. With an ISSN of 2590-1362 and operating since 2019, the journal has rapidly established an influential role, achieving Q2 rankings in major categories such as Immunology and Microbiology, Infectious Diseases, and Public Health for 2023. Its commitment to disseminating cutting-edge research is evident from its broad scope, focusing on innovative vaccines and therapies that are critical for global health. Researchers and professionals will find value in the accessible nature of the journal, which has been recognized for its contributions to veterinary medicine as well, with a Q1 ranking in the miscellaneous veterinary category. The journal proudly showcases high-quality, peer-reviewed articles and welcomes submissions that push the boundaries of current knowledge, making it an essential resource for anyone involved in vaccine research and development.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.